| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 13, 2025 | EXAS Exact Sciences Corp | Zanotti Katherine S50 | Director | Sell | 3,207 | $53.20 | $170,612.40 | -4.2% | +4.6% | - | |
| Jun 13, 2025 | NTRA Natera, Inc. | Rabinowitz Matthew59 | Executive Chairman | Sell | 54,000 | $155.26 | $8,384,150.00 | -15.1% | +5.1% | - | |
| Jun 12, 2025 | GRAL Grail, Inc. | Ofman Joshua J. | President | Sell | 9,692 | $42.30 | $410,019.09 | -1.9% | -15.5% | - | |
| Jun 11, 2025 | CDNA Caredx, Inc. | Hagstrom William A61 | Director | Sell | 19,391 | $19.90 | $385,917.74 | -26.4% | -33.0% | - | |
| Jun 10, 2025 | NTRA Natera, Inc. | Marcus Gail Boxer | Director | Sell | 4,000 | $164.44 | $657,760.90 | -25.0% | +1.3% | - | |
| Jun 9, 2025 | WGS Genedx Holdings Corp. | Stueland Katherine | Chief Executive Officer | Sell | 3,639 | $72.55 | $264,009.45 | -36.4% | +78.6% | - | |
| Jun 9, 2025 | WGS Genedx Holdings Corp. | Feeley Kevin46 | Chief Financial Officer | Sell | 1,266 | $72.55 | $91,848.30 | -19.3% | +78.6% | - | |
| Jun 9, 2025 | GH Guardant Health, Inc. | Talasaz Amirali | Co-chief Executive Officer | Sell | 119,284 | $50.09 | $5,974,363.95 | -1.8% | +21.5% | - | |
| Jun 6, 2025 | TWST Twist Bioscience Corp | Leproust Emily M.77 | Chief Executive Officer | Sell | 2,170 | $31.75 | $68,897.50 | -0.3% | -18.8% | +115.0% | |
| Jun 6, 2025 | TWST Twist Bioscience Corp | Werner Robert F.63 | Chief Accounting Officer | Sell | 225 | $31.75 | $7,143.75 | -0.4% | -18.8% | +115.0% | |
| Jun 6, 2025 | TWST Twist Bioscience Corp | Green Paula69 | SVP Of Human Resources | Sell | 853 | $31.75 | $27,082.75 | -0.7% | -18.8% | +115.0% | |
| Jun 6, 2025 | TWST Twist Bioscience Corp | Cho Dennis70 | See Remarks | Sell | 257 | $31.75 | $8,159.75 | -0.2% | -18.8% | +115.0% | |
| Jun 5, 2025 | RDNT Radnet, Inc. | Murdock Michael N | EVP, Mergers And Acquisitions | Sell | 11,132 | $58.05 | $646,212.60 | -20.5% | +22.2% | -10.7% | |
| Jun 4, 2025 | VCYT Veracyte, Inc. | Leite John51 | Chief Commercial Officer-clia | Sell | 2,809 | $27.20 | $76,409.86 | -2.9% | +10.3% | +76.5% | |
| Jun 3, 2025 | GH Guardant Health, Inc. | Kalia Kumud61 | Chief Information Officer | Sell | 4,000 | $46.39 | $185,561.60 | -17.6% | +45.3% | +182.0% | |
| Jun 2, 2025 | FLGT Fulgent Genetics, Inc. | Xie Jian77 | President And COO | Sell | 1,135 | $20.29 | $23,030.06 | -0.3% | +7.9% | -9.5% | |
| Jun 2, 2025 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 6,111 | $157.10 | $960,062.44 | -1.1% | +5.4% | +36.2% | |
| Jun 2, 2025 | GH Guardant Health, Inc. | Joyce Meghan V.56 | Director | Sell | 100 | $41.66 | $4,166.00 | -1.3% | +58.0% | +206.7% | |
| Jun 2, 2025 | NTRA Natera, Inc. | Moshkevich Solomon | President, Clinicaldiagnostics | Sell | 3,000 | $157.07 | $471,212.07 | -0.6% | +5.4% | +36.2% | |
| Jun 2, 2025 | NOTV Inotiv, Inc. | Neff R Matthew92 | Director | Sell | 2,000 | $2.62 | $5,246.00 | -1.3% | -41.0% | -89.4% | |
| Jun 2, 2025 | FLGT Fulgent Genetics, Inc. | Gao Hanlin73 | Chief Scientific Officer | Sell | 754 | $20.29 | $15,299.26 | - | +7.9% | -9.5% | |
| Jun 2, 2025 | WGS Genedx Holdings Corp. | Feeley Kevin46 | Chief Financial Officer | Sell | 370 | $71.26 | $26,366.20 | -8.3% | +72.9% | -29.9% | |
| May 30, 2025 | PRPO Precipio, Inc. | Sandberg Richard A64 | Director | Buy | 1,399 | $10.00 | $13,985.52 | +1.8% | +63.7% | +141.5% | |
| May 29, 2025 | RVTY Revvity, Inc. | McMurry-Heath Michelle50 | Director | Sell | 600 | $92.17 | $55,299.00 | -11.0% | -3.6% | +13.8% | |
| May 28, 2025 | CDNA Caredx, Inc. | Hagstrom William A61 | Director | Sell | 30,000 | $17.45 | $523,413.00 | -35.7% | -27.1% | +29.3% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.